Targeting metastatic colorectal cancer – present and emerging treatment options

Por Ciombor, Kristen K, Berlin, Jordan
Publicado em 2014

Aflibercept—a Decoy VEGF Receptor

Por Ciombor, Kristen K., Berlin, Jordan
Publicado no Curr Oncol Rep (2014)

Current Therapy and Future Directions in Biliary Tract Malignancies

Por Ciombor, Kristen K., Goff, Laura W.
Publicado em 2013

Update on Anti-Angiogenesis Therapy in Colorectal Cancer

Por Ciombor, Kristen K., Goldberg, Richard M.
Publicado no Curr Colorectal Cancer Rep (2015)

A Comprehensive Review of Sequencing and Combination Strategies of Targeted Agents in Metastatic Colorectal Cancer

Por Ciombor, Kristen K., Bekaii‐Saab, Tanios
Publicado no Oncologist (2017)

Current evidence and controversies in the incorporation of biologics for metastatic colorectal cancer

Por Ciombor, Kristen K, Goldberg, Richard M
Publicado no Hepat Oncol (2014)

Aflibercept

Por Ciombor, Kristen K., Berlin, Jordan, Chan, Emily
Publicado em 2013

How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?

Por Ciombor, Kristen K., Haraldsdottir, Sigurdis, Goldberg, Richard M.
Publicado no Curr Colorectal Cancer Rep (2014)

Promising New Agents for Colorectal Cancer

Por Das, Satya, Ciombor, Kristen K., Haraldsdottir, Sigurdis, Goldberg, Richard M.
Publicado no Curr Treat Options Oncol (2018)

Genomic diversity of colorectal cancer: Changing landscape and emerging targets

Por Ahn, Daniel H, Ciombor, Kristen K, Mikhail, Sameh, Bekaii-Saab, Tanios
Publicado no World J Gastroenterol (2016)

Early detection of SARS-CoV-2 from staging PET-CT

Por Khattab, Mohamed H., Sherry, Alexander D., Jessop, Aaron C., Ciombor, Kristen K., Chakravarthy, Bapsi
Publicado no J Radiat Oncol (2020)

A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis

Por Ahn, Daniel H., Krishna, Kavya, Blazer, Marlo, Reardon, Joshua, Wei, Lai, Wu, Christina, Ciombor, Kristen K., Noonan, Anne M., Mikhail, Sameh, Bekaii-Saab, Tanios
Publicado no Ther Adv Med Oncol (2016)

Evaluation of frozen tissue-derived prognostic gene expression signatures in FFPE colorectal cancer samples

Por Zhu, Jing, Deane, Natasha G., Lewis, Keeli B., Padmanabhan, Chandrasekhar, Washington, M. Kay, Ciombor, Kristen K., Timmers, Cynthia, Goldberg, Richard M., Beauchamp, R. Daniel, Chen, Xi
Publicado no Sci Rep (2016)

Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group

Por Ciombor, Kristen K., Feng, Yang, Benson, Al Bowen, Su, Yingjun, Horton, Linda, Short, Sarah P., Kauh, John Sae Wook, Staley, Charles, Mulcahy, Mary, Powell, Mark, Amiri, Katayoun I., Richmond, Ann, Berlin, Jordan
Publicado em 2014

NFAT transcriptional activity is associated with metastatic capacity in colon cancer

Por Tripathi, Manish K., Deane, Natasha G., Zhu, Jing, An, Hanbing, Mima, Shinji, Wang, Xiaojing, Padmanabhan, Sekhar, Shi, Zhiao, Prodduturi, Naresh, Ciombor, Kristen K., Chen, Xi, Washington, M. Kay, Zhang, Bing, Beauchamp, R. Daniel
Publicado no Cancer Res (2014)

A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers

Por Goff, Laura W., Cardin, Dana B., Whisenant, Jennifer G., Du, Liping, Koyama, Tatsuki, Dahlman, Kimberly B., Salaria, Safia N., Young, Ruth T., Ciombor, Kristen K., Gilbert, Jill, Smith, Stephen James, Chan, Emily, Berlin, Jordan
Publicado no Invest New Drugs (2016)

Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

Por Wu, Christina, Williams, Terence M., Robb, Ryan, Webb, Amy, Wei, Lai, Chen, Wei, Mikhail, Sameh, Ciombor, Kristen K., Cardin, Dana, Timmers, Cynthia, Krishna, Somashekar, Arnold, Mark, Harzman, Alan, Abdel-Misih, Sherif, Roychowdhury, Sameek, Bekaii-Saab, Tanios, Wuthrick, Evan J.
Publicado no Clin Cancer Res (2020)

Immune‐Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration‐Approved Indications for Immunothe...

Por Das, Satya, Ciombor, Kristen K., Haraldsdottir, Sigurdis, Pumpalova, Yoanna, Sahin, Ibrahim H., Pineda, G., Shyr, Yu, Lin, E.P., Hsu, Chih‐Yuan, Chu, Shih‐Kai, Goff, Laura W., Cardin, Dana B., Bilen, Mehmet A., Fisher, George A., Wu, Christina, Berlin, Jordan
Publicado no Oncologist (2020)

Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma

Por Krook, Melanie A., Lenyo, Alexandria, Wilberding, Max, Barker, Hannah, Dantuono, Mikayla, Bailey, Kelly M., Chen, Hui-Zi, Reeser, Julie W., Wing, Michele R., Miya, Jharna, Samorodnitsky, Eric, Smith, Amy M., Dao, Thuy, Martin, Dorrelyn M., Ciombor, Kristen K., Hays, John, Freud, Aharon G., Roychowdhury, Sameek
Publicado no Mol Cancer Ther (2020)

Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma

Por Noonan, Anne M, Farren, Matthew R, Geyer, Susan M, Huang, Ying, Tahiri, Sanaa, Ahn, Daniel, Mikhail, Sameh, Ciombor, Kristen K, Pant, Shubham, Aparo, Santiago, Sexton, Jennifer, Marshall, John L, Mace, Thomas A, Wu, Christina S, El-Rayes, Bassel, Timmers, Cynthia D, Zwiebel, James, Lesinski, Gregory B, Villalona-Calero, Miguel A, Bekaii-Saab, Tanios S
Publicado no Mol Ther (2016)